PAF and its metabolic enzymes in healthy volunteers: Interrelations and correlations with basic characteristics

Demopoulos, 1979, Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators), J Biol Chem, 254, 9355, 10.1016/S0021-9258(19)83523-8 Sakellariou, 2008, Intravenous infusion of PAF affects ovulation, fertilization and preimplantation embryonic development in NZB×NZW F1 hybrid mice, Prostaglandins Other Lipid Mediat, 85, 125, 10.1016/j.prostaglandins.2007.11.003 Demopoulos, 2003, Platelet activating factor – a molecular link between atherosclerosis theories, Eur J Lipid Sci Technol, 105, 705, 10.1002/ejlt.200300845 Vadas, 2008, Platelet-activating factor PAF acetylhydrolase, and severe anaphylaxis, N Engl J Med, 358, 28, 10.1056/NEJMoa070030 Tsoupras, 2009, The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants, Infect Disord Drug Targets, 9, 390, 10.2174/187152609788922555 Antonopoulou, 2009, PAF a potent lipid mediator, 85 Snyder, 1995, Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes, Biochim Biophys Acta, 1254, 231, 10.1016/0005-2760(94)00192-2 Shindou, 2007, A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:lyso-PAF acetyltransferase, J Biol Chem, 282, 6532, 10.1074/jbc.M609641200 Harayama, 2008, Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor, J Biol Chem, 283, 11097, 10.1074/jbc.M708909200 Snyder, 1997, alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor, Biochim Biophys Acta, 4, 111, 10.1016/S0005-2760(97)00109-4 Stafforini, 2009, Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2), Cardiovasc Drugs Ther, 23, 73, 10.1007/s10557-008-6133-8 Tellis, 2009, The role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma, Biochim Biophys Acta, 1971, 327, 10.1016/j.bbalip.2009.02.015 Thompson, 2010, Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies, Lancet, 375, 1536, 10.1016/S0140-6736(10)60319-4 Detopoulou, 2009, Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure, Clin Biochem, 42, 44, 10.1016/j.clinbiochem.2008.09.113 Bradford, 1976, Rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein–dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Demopoulos, 1994, A simple and precise method for the routine determination of platelet-activating factor in blood and urine, Lipids, 29, 305, 10.1007/BF02536336 Bligh, 1959, A rapid method of total lipid extraction and purification, Can J Biochem Physiol, 37, 911, 10.1139/o59-099 Nomikos, 2003, Acetyl-CoA.1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue, Eur J Biochem, 270, 2992, 10.1046/j.1432-1033.2003.03676.x Tsoupras, 2007, Characterization of the de novo biosynthetic enzyme of platelet activating factor DDT-insensitive cholinephosphotransferase, of human mesangial cells, Mediators Inflamm, 2007, 27683, 10.1155/2007/27683 Demopoulos, 1990, PAF of biological fluids in disease: I. Levels in blood and urine in cancer, Clin Chem Enzym Comms, 3, 41 Antonopoulou, 2003, Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients, Mediators Inflamm, 12, 221, 10.1080/09629350310001599666 Iatrou, 1996, Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis, Nephron, 72, 611, 10.1159/000188948 Nathan, 1992, Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus, Diabete Metab, 18, 59 Labrakis-Lazanas, 1988, PAF of biological fluids in disease: blood levels in allergic rhinitis, Haematologica, 73, 379 Izaki, 1996, Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation, Br J Dermatol, 134, 1060, 10.1111/j.1365-2133.1996.tb07943.x Denizot, 2001, Is there a role of platelet-activating factor in human lung cancer?, Lung Cancer, 33, 195, 10.1016/S0169-5002(01)00197-0 Yang, 2004, Creation of reversed phase high-performance liquid chromatographic technique to assay platelet-activating factor, J Zhejiang Univ Sci, 5, 738, 10.1631/jzus.2004.0738 Cao, 2005, Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis, World J Gastroenterol, 11, 7364, 10.3748/wjg.v11.i46.7364 Tselepis, 2009, Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study, Atherosclerosis, 206, 303, 10.1016/j.atherosclerosis.2009.02.016 Baker, 2002, Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases, Biochim Biophys Acta, 1592, 175, 10.1016/S0167-4889(02)00314-2 Misso, 1996, lyso-PAF acetyltransferase activity in neutrophils of patients during acute asthma and after recovery, Eur Respir J, 9, 2243, 10.1183/09031936.96.09112243 Polk, 2005, Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation, Curr Cardiol Rep, 7, 166, 10.1007/s11886-005-0072-9 Bisoendial, 2009, C-reactive protein elicits white blood cell activation in humans, Am J Med, 122, e1 Gomes, 2008, Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes, Prostaglandins Other Lipid Mediat, 87, 42, 10.1016/j.prostaglandins.2008.07.001 Zhang, 2003, Age-related increase of plasma platelet-activating factor concentrations in Chinese, Clin Chim Acta, 337, 157, 10.1016/j.cccn.2003.08.010 Morimoto, 2010, Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages, J Biol Chem, 285, 29857, 10.1074/jbc.M110.147025 Kudolo, 1997, Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney, J Lipid Mediat Cell Signal, 16, 23, 10.1016/S0929-7855(96)00565-2 Hines, 1991, PAF increases hepatic vascular resistance and glycogenolysis in vivo, Am J Physiol, 260, G471 Maziere, 1988, PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts, FEBS Lett, 236, 115, 10.1016/0014-5793(88)80296-5 Mimura, 1991, Effect of platelet-activating factor on lipoprotein lipase and blood lipids, Lipids, 26, 1102, 10.1007/BF02536510 Howard, 2011, Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways, Inflamm Res, 60, 735, 10.1007/s00011-011-0326-5 Ibe, 2002, Metabolism of platelet activating factor by intrapulmonary vascular smooth muscle cells Effect of oxygen on phospholipase A2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase, Mol Genet Metab, 77, 237, 10.1016/S1096-7192(02)00147-6 Nieto, 1988, Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. Involvement of the cholinephosphotransferase pathway in response to the phorbol esters, J Biol Chem, 263, 2217, 10.1016/S0021-9258(18)69193-8 Valone, 1988, Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma, J Immunol, 141, 3945, 10.4049/jimmunol.141.11.3945 Tosaki, 2007, Enhancement of acetyl-CoA: 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity by hydrogen peroxide, Biol Pharm Bull, 30, 272, 10.1248/bpb.30.272 Detopoulou, 2009, Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults, Lipids Health Dis, 8, 19, 10.1186/1476-511X-8-19